Affordable HIV-Prevention Shot Approved, Offering New Hope for Low-Income Nations

11/02/2026

The U.S. Food and Drug Administration has approved a generic version of the world’s only twice-a-year shot to prevent HIV — a big step toward making the drug available inexpensively and more...

11/02/2026

The U.S. Food and Drug Administration has approved a generic version of the world's only twice-a-year shot to prevent HIV — a big step toward making the drug available inexpensively and more...

11/02/2026

US regulators have approved a generic version of lenacapavir, a long-acting HIV-prevention drug, for sale in low-income countries, potentially widening access to preventive treatment.

11/02/2026

The Lenacapavir injection will cost just $40 a year in 120 countries, in what is seen as a major step towards ending Aids